AI Brain Health Leader Omniscient Closes Series C Funding Round Omniscient secures Series C funding to expand Quicktome® platform, advancing connectomics for improved brain health diagnostics and treatments.

Omniscient Announces FDA-Clearance of New MRI-based Functional Brain Analysis Technology FDA-cleared AI brain-mapping software, Quicktome FC (Functional Connectome), maps functional connectivity of a patient’s unique networks - involved in crucial functions such as movement, language, and...

Omniscient Neurotechnology Appoints Two New Members to Its Board of Directors SYDNEY, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Omniscient Neurotechnology, the brain mapping company creating new possibilities in brain health, today announced the appointment of Barbara...